The Rise of China: From Science Cities to Global Ambition
By James Strachan, Kathryn Wighton
July 15, 2026
Daphne Smyth of Veristat on the rise of Chinese biopharma, regulatory realities, and what comes next
8 min read
False
Advertisement
Regulation & Standards
FDA Selects Seven Companies for Drug Manufacturing Pilot
July 13, 2026
Selected companies will receive earlier FDA engagement to support new US drug manufacturing facilities across small molecules, biologics, sterile injectables, and advanced therapies
2 min read
Bioprocessing
Interviews
Regulation & Standards
Standards & Regulation
Quality & Compliance
Technology & Manufacturing
Sponsored
Moving Beyond Document-Based Validation
July 2, 2026
How UCB is improving traceability, audit readiness, and visibility.
1 min read
Why Early QC Planning Matters in Cell and Gene Therapy
By Laurent Claisse
June 30, 2026
Late-stage CMC setbacks often begin with early QC decisions that shape cell and gene therapy timelines, costs, and regulatory outcomes
7 min read
Reformulating the Future of Small Molecules
June 30, 2026
A special collection of recent stories exploring oral dose innovation, API stability, nitrosamine testing, and the evolving science of small molecule medicines
1 min read
Bioprocessing
Interviews
Technology & Manufacturing
Digital Technologies
Quality & Compliance
Regulation & Standards
Sponsored
How Zealand Pharma Is Scaling Quality Without Complexity
June 29, 2026
How connected quality systems can help growing biotechs remain agile.
0 min read
Cell & Gene
Development & Clinical
Outsourcing
Regulation & Standards
Business & Trends
Technology & Manufacturing
Roving Reporter Asks: What Are Recent Breakthroughs Telling Us About the CGT Field’s Maturity?
June 25, 2026
IBTV speaks with industry leaders at ARM’s Meeting on the Med 2026 to explore what recent clinical, regulatory, and commercial milestones reveal about the next phase of cell and gene therapy
Why Refrigerants Are the Next Critical Sustainability Frontier
By Lu Wang
June 18, 2026
With stricter regulations on the horizon, biopharma labs are being forced to rethink how they cool, store, and protect critical samples
5 min read
AI in Drug Development: Moving Beyond Early Use Cases
By Crystal Allard, Pratyusha Pallavi
June 10, 2026
As new rules take hold, what does “good AI practice” look like in drug development?
6 min read
A Regulatory Roadmap for Early-Stage Biotech
By Tim Stonehouse
April 28, 2026
From first conversations with regulators to global market strategy, early decisions shape speed, risk, and long-term success
3 min read
